Quidel Stock Today
| QDEL Stock | USD 35.93 0.77 2.19% |
PerformanceVery Weak
| Odds Of DistressBelow Average
|
Quidel is selling for 35.93 as of the 22nd of March 2025. This is a 2.19% increase since the beginning of the trading day. The stock's lowest day price was 34.66. Quidel has about a 32 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 2nd of April 2023 and ending today, the 22nd of March 2025. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 1st of February 1991 | Category Healthcare | Classification Health Care |
QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company was founded in 1979 and is headquartered in San Diego, California. Quidelortho Corp operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. The company has 67.45 M outstanding shares of which 4.35 M shares are at this time shorted by private and institutional investors with about 4.94 trading days to cover. More on Quidel
Moving together with Quidel Stock
Moving against Quidel Stock
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
Quidel Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO and President and Director | Douglas Bryant | ||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, SP Small-Cap 600, NASDAQ Composite Total, NASDAQ Composite, Health Care, Health Care Equipment & Supplies, Medical Instruments & Supplies, Healthcare (View all Sectors) | ||||
| Average Analyst Recommendation | |||||
| Debt LevelsQuidel can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Quidel's financial leverage. It provides some insight into what part of Quidel's total assets is financed by creditors.
LiquidityQuidel currently holds 509 M in liabilities with Debt to Equity (D/E) ratio of 0.6, which is about average as compared to similar companies. Quidel has a current ratio of 1.63, which is within standard range for the sector. Note, when we think about Quidel's use of debt, we should always consider it together with its cash and equity.
| |||||
Quidel (QDEL) is traded on NASDAQ Exchange in USA. It is located in 9975 Summers Ridge Road, San Diego, CA, United States, 92121 and employs 6,600 people. Quidel is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.37 B. Quidel conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 67.45 M outstanding shares of which 4.35 M shares are at this time shorted by private and institutional investors with about 4.94 trading days to cover.
Quidel currently holds about 264 M in cash with 83 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.0.
Check Quidel Probability Of Bankruptcy
Ownership AllocationThe majority of Quidel outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in Quidel to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Quidel. Please pay attention to any change in the institutional holdings of Quidel as this could imply that something significant has changed or is about to change at the company.
Check Quidel Ownership Details
Quidel Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Newtyn Management Llc | 2024-12-31 | 1.2 M | |
| American Century Companies Inc | 2024-12-31 | 1.1 M | |
| Millennium Management Llc | 2024-12-31 | 1.1 M | |
| Geode Capital Management, Llc | 2024-12-31 | 1.1 M | |
| Segall Bryant & Hamill | 2024-12-31 | 1 M | |
| Goldman Sachs Group Inc | 2024-12-31 | 1 M | |
| Van Lanschot Kempen Investment Management Nv | 2024-12-31 | 968.1 K | |
| Charles Schwab Investment Management Inc | 2024-12-31 | 881.5 K | |
| Magnetar Financial Llc | 2024-12-31 | 877.3 K | |
| T. Rowe Price Investment Management,inc. | 2024-12-31 | 11.2 M | |
| Blackrock Inc | 2024-12-31 | 8.4 M |
Quidel Historical Income Statement
Quidel Stock Against Markets
Quidel Corporate Management
| Ruben Argueta | Director Relations | Profile | |
| Juliet Cunningham | Vice Relations | Profile | |
| Michelle JD | Chief Officer | Profile | |
| Chockalingam Palaniappan | Chief Officer | Profile | |
| Joseph CPA | Chief Officer | Profile | |
| Louise Brandy | Senior Officer | Profile | |
| Tamara Ranalli | Molecular Leader | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Quidel. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. For more information on how to buy Quidel Stock please use our How to buy in Quidel Stock guide.You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Quidel. If investors know Quidel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Quidel listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.77) | Earnings Share (30.54) | Revenue Per Share | Quarterly Revenue Growth (0.05) | Return On Assets |
The market value of Quidel is measured differently than its book value, which is the value of Quidel that is recorded on the company's balance sheet. Investors also form their own opinion of Quidel's value that differs from its market value or its book value, called intrinsic value, which is Quidel's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Quidel's market value can be influenced by many factors that don't directly affect Quidel's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Quidel's value and its price as these two are different measures arrived at by different means. Investors typically determine if Quidel is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Quidel's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.